Reaction
Babesiosis reporting signals
As of the last recalculation, Babesiosis appears in 277 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is ATOVAQUONE (PRR 729.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Atovaquone | 61 | 729.8 | 735.4 |
| Blinatumomab | 15 | 114.2 | 114.3 |
| Quinine | 12 | 109.9 | 110.0 |
| Clindamycin | 34 | 102.4 | 102.6 |
| Clindamycin Phosphate | 35 | 90.0 | 90.1 |
| Azithromycin | 38 | 82.1 | 82.2 |
| Azithromycin Monohydrate | 38 | 79.3 | 79.4 |
| Acalabrutinib | 8 | 51.0 | 51.1 |
| Sirolimus | 8 | 45.9 | 45.9 |
| Bendamustine Hcl | 9 | 45.0 | 45.1 |
| Ocrelizumab | 20 | 26.0 | 26.0 |